Latest Regulatory News

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Odyssey Gold has initiated a Technical Study to explore mining and processing strategies for its Tuckanarra Project, leveraging a new partnership with Monument Murchison Ltd to potentially process ore at the nearby Burnakura Mill.

Core Lithium Ltd progresses its Finniss Lithium Project Restart Study, securing full ownership of site infrastructure and reporting promising gold exploration results at Shoobridge.

MRG Metals has advanced its Mozambique joint venture with Sinowin Lithium, securing the Corridor Central mining licence and confirming high-grade heavy mineral sands at Marao’s Magonde target through recent assay results.

Midas Minerals advances six drill-ready gold targets at its Newington Project in WA, with significant historic intercepts underpinning upcoming exploration plans. Meanwhile, ongoing work at the Challa Project promises further assay results in the June quarter.

Triangle Energy reported a $9.85 million cash balance for the March quarter, plugged the Becos-1 well after disappointing results, and agreed to defer the Cliff Head asset sale to Pilot Energy until 2026.

Recharge Metals Limited has made significant strides in its uranium and copper exploration projects, progressing drill planning and stakeholder engagement at its Carter Uranium Project in Montana and identifying new copper targets at Brandy Hill South in Western Australia.

Donaco International reported a modest revenue and EBITDA decline in Q3 FY2025 but strengthened its cash reserves. Meanwhile, the company agreed to a full acquisition scheme at a significant premium, setting the stage for shareholder decisions amid regulatory uncertainties.

Locksley Resources reports exceptional antimony and silver assays at its Mojave Project, while new mineralised zones emerge at Tottenham. Regulatory shifts in the US could accelerate Mojave’s permitting timeline.

Immutep Limited has dosed the first patient in its pivotal Phase III lung cancer trial and completed enrolments in multiple studies, supported by a robust cash position expected to fund operations through 2026.